📰 Robert Uhl News
Robert Uhl News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Robert Uhl. Real-time updates on events, politics, business and more.
June 19, 2024
Box upstairs and read it and go, holy cow you dont have holy cow experiences often, but when they come, its really a thrill for researchers, and that keeps us going. This book exists today because i gave in to one of those deep dark desires that lurks in the depths of the human soul. I refer to the desire to prove that your boss is full of bolonga. This happened in 2010. I was hired as a editor at American History magazine, and i immediately made a suggestion to the honcho of the place who just ...
August 12, 2023
Operator: Good afternoon, ladies and gentlemen, and welcome to the Celcuity Second Quarter 2023 Earnings Conference Call. At this time, all lines are in a listen-only mode.
August 4, 2023
SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today...
August 3, 2023
03.08.2023 - MINNEAPOLIS, Aug. 03, 2023 (GLOBE NEWSWIRE) - Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company focused on development of targeted therapies for oncology, today announced that it will release its financial results for the second ...
July 14, 2023
SAN MATEO, Calif., July 13, 2023 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (“Sagimet”) (Nasdaq: SGMT), a clinical-stage biopharmaceutical company...
June 23, 2023
Denifanstat was well-tolerated and met primary endpoint in planned interim readout with 67% of treated patients achieving ≥30% reductions in liver fat at week 26 compared to 18% placebo (p<0.001)
May 25, 2023
DMK CEO, Ebrahim (Eboo) Versi, MD, PhD, named CEO and Chairman of the combined companyCombined company will have commercial products and a library of...
May 24, 2023
Celcuity to Participate in Upcoming Craig-Hallum and Jefferies Investor ...
May 19, 2023
SAN DIEGO, May 19, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, announced today that it will effect a 1-for-70 reverse stock
May 17, 2023
Operator: Greetings and welcome to Celcuity First Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.